Demand for Toad Venom Rises Along With the Booming Psychedelics Market
Depression and anxiety affect millions around the world and the venom of a toad is the latest psychedelic compound being used as an alternative treatment. The Sonoran desert toad is the only animal on earth ... [Read]
Why Incannex Healthcare Limited’s Stock Is Soaring Today
Image The stock market had an impressive day on Tuesday, recovering from a downturn caused by the tensions in Ukraine and general fears of an economic slowdown. However, Incannex Healthcare Limited (NASDAQ:IXHL) was a big ... [Read]
Biotech Stocks Hitting the Public Market This Year: Best Ones to Watch
Last year was a record year for biotech stocks, with an impressive number of companies going public and raising a significant amount of money in the space. In fact, in 2018 there were 80 biotech ... [Read]
ABIO Stock Gets Attention: Are You Watching ARCA Biopharma?
ABIO stock has been on fire over the past two trading sessions, with a huge jump of 150%. As far as biopharmaceutical companies are concerned, positive news of some variety can often send the stock ... [Read]
ARQL Stock Doubles in 2 Months: What to Do with ArQule Now?
ARQL stock is on fire this year, and much of those gains are due to ArQule Inc’s (NASDAQ:ARQL) handsome cash balance and developments that bode well for its flagship drug, ARQ 531. The Burlington, Massachusetts-based ... [Read]
ADMA Stock Receives Consensus “Buy” Rating, Major Upswing Ahead?
ADMA stock has just received a consensus rating of “Buy” from nine brokerages covering the stock. With all in agreement, why are analysts bullish on this biotechnology stock? Let’s find out! AMDA Stock Selling for ... [Read]
AXSM Stock Climbs 550%: Key Drivers Investors Should Be Looking For
Little known biopharmaceutical AXSM stock has been on a tear, and the stock has jumped by a staggering 550% as big news regarding one of the Axsome Therapeutics Inc’s (NASDAQ:AXSM) drugs proved decisive for many ... [Read]
IPATF Stock Soars: Subsidiary Receives Exclusive License from Stanford
On Friday, April 26, ImmunoPrecise Antibodies’ subsidiary U-Protein Express disclosed that it’s obtained an exclusive license from Stanford University. The license allows U-Protein Express to manufacture and sell Wnt surrogate Fc. On the news, IPATF ... [Read]
ImmunoPrecise Antibodies’ Subsidiary U-Protein Express Announces Exclusive Agreement as Global Supplier for Wnt-Surrogate-Fc Growth Factor
VICTORIA, April 25, 2019 /CNW/ – ImmunoPrecise Antibodies Ltd.(TSX:IPA)(OTC:IPATF)(FRA: TQB2)(the “Company” or “IPA”) U-Protein Express, a wholly-owned ImmunoPrecise Antibodies subsidiary, in Utrech, Netherlands, announced that it has obtained an exclusive license from Stanford University to ... [Read]
AKTX Stock Flying after Announcing Positive Phase 2 Clinical Trial Data
Akari Therapeutics (NASDAQ:AKTX) is making headlines after the biopharmaceutical company announced positive data from a Phase 2 clinical trial. The news, released today, sent AKTX stock up nearly 20% at the time of writing. AKTX ... [Read]